Sven Theobald

Innovation in Health & Agriculture. Brand-driven Transformation & Value. Global Comms @ #TeamBayer. Views are my own.🚀

[Bayer AG @Bayer]

#News: The U.S. FDA has approved new hormone-free treatment option for menopause.

Learn more: https://t.co/TbgNTmBcsr

#TeamBayer #HealthForAll #HungerForNone

[Bayer AG @Bayer]

Earlier today, we published our Q3 2025 results. Our CEO, Bill Anderson, provides a 90-second overview of the progress we made and where we will put our focus for the next 90 days: https://t.co/YzMKzONXNz

[Bayer AG @Bayer]

#News: The European Commission has approved our new hormone-free treatment option for vasomotor symptoms (VMS; also known as hot flashes) associated with menopause or caused by endocrine therapy for breast cancer.

[Bayer AG @Bayer]

#NEWS: #TeamBayer, together with @ask_bio and @BlueRockTx, has reached significant milestones towards developing innovative treatments for patients with Parkinson's Disease. Learn more: https://t.co/feCeNRhD8S

[Bayer AG @Bayer]

Earlier today, we published our HY1 2025 results. Our CEO Bill Anderson provides a 90-second overview of the figures from the first half and a look into the rest of 2025: https://t.co/Qiiz2qbL7r

[Bayer AG @Bayer]

+++ A landmark launch year for Bayer Pharmaceuticals +++

Today, at our annual Pharma Media Day, we unveiled key advancements in our long-term growth strategy.
#TeamBayer #PharmaMediaDay #PMD25

[Bayer AG @Bayer]

#News: Bayer and @BlueRockTx are taking a significant step forward in the fight against Parkinson's disease with the planned initiation of a Phase III clinical trial for an investigational stem cell derived therapy.

Learn more: https://t.co/feCeNRhD8S

[Bayer AG @Bayer]

#NEWS: #TeamBayer is excited to share the latest progress in our pharmaceutical growth strategy and pipeline at #JPM2025. We are focused on addressing the most significant unmet needs for patients globally through industry-leading scientific innovation: https://t.co/uPwbo6VmKz

[Matthias Berninger @berninger71]

Mit dem @handelsblatt habe ich über den Umgang mit den Glyphosat-Klagen gesprochen. Wir brauchen Rechtssicherheit. Es kann nicht sein, dass wir in einzelnen US-Bundesstaaten für ein Produkt verklagt werden, das die zuständige Bundesbehörde als sicher bestätigt hat. 👇

[Bayer AG @Bayer]

Our CEO Bill Anderson shares our first half results and the advances we’ve made on our strategy in #Q2. 90 day of progress in 90 seconds or less.

Check it out! 👇

[Matthias Berninger @berninger71]

Join me in this edition of #120months as I share my vision for a more science-driven debate around new genomic techniques – and for a policy approach that will better harness their huge potential for helping ensure global food security.
https://t.co/cfM2n30RGc

[Bayer AG @Bayer]

+++ #NEWS+++
We are pleased to announce topline results from a Phase III study in patients with heart failure with mildly reduced or preserved ejection fraction. Learn more: https://t.co/feCeNRhD8S
#TeamBayer #HealthForAll #HungerForNone

[Bayer AG @Bayer]

#news: Bayer submits new drug application to U.S. FDA for approval of our non-hormonal investigational compound for menopause.
Learn more: https://t.co/lVPocIOS15

#WomensHealth #TeamBayer

[Bayer AG @Bayer]

#News: @ask_bio’s investigational gene therapy AB-1005 for Parkinson’s disease secures FDA Fast Tack designation & the UK MHRA Innovation Passport. This shows the dedication to advancing innovative therapies for neurodegenerative diseases.
Learn more: https://t.co/1OO91iNgqB

[Bayer AG @Bayer]

#NEWS: Bayer and @ChariteBerlin kick off Berlin Center for Gene and Cell Therapies.
@stefanoelrich explains how the Center aims to bring medical innovations to patients quicker by integrating research, development & manufacturing of cell & gene therapies: https://t.co/BXyg4YUbPV

[Sven Theobald @SvenTheobald]

For the third year in a row, @Bayer has been ranked by @BrandFinance as the most valuable AgriScience brand in the world. We are also listed among the top 10 most valuable Pharma brands with a stable financial value of $5.49 billion. #TeamBayer #Healthforall #Hungerfornone

[Bayer AG @Bayer]

+++ #News +++
#TeamBayer and @Samsung are joining forces to close the knowledge gap on the impact of sleep disturbances in menopause.
Leveraging wearable tech, we're on a mission to improve women's health & quality of life.
Learn more: https://t.co/yX6rR7B16A

[Bayer 04 Leverkusen @bayer04_en]

Make yourself heard! 🗣️

Remember to cast your vote in the European elections between 6-9 June 🗳️

@Europarl_EN #UseYourVote